x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Assignment Study to Assess the Efficacy and Safety of Reparixin in Pancreatic Islet Auto-Transplantation
Principal Investigator (?)
Study Number
F14223
Summary
The study will be a phase 2/3, multicenter, double-blind, parallel assignment study. It will involve 100 adult recipients of an intra-hepatic pancreatic Islet Auto-Transplantation (IAT). The objective of this clinical trial is to assess whether reparixin leads to improved transplant outcome as measured by the proportion of insulin-independent patients following IAT. The safety of reparixin in the specific clinical setting will be also evaluated. 
Phase (?)
Phase III
Sponsor (?)
Contact

Jessica Chevalier

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0